Schedule 13G ownership disclosure

Fennec Pharmaceuticals Inc

Common Shares · CUSIP: 31447P100

Event date: 2025-09-30

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Rosalind Advisors, Inc.

    Shares: 2,076,840.00 · Class: 7.5%

  • SALAMON STEVEN A J

    Shares: 2,076,840.00 · Class: 7.5%

  • Aharon Gil

    Shares: 2,076,840.00 · Class: 7.5%

  • Rosalind Master Fund L.P.

    Shares: 2,076,840.00 · Class: 7.5%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001622627-25-000039
Form type
SCHEDULE 13G
Filer
FENNEC PHARMACEUTICALS INC.
CIK
CIK 1211583
Filed
Nov 13, 2025
Reporting period
Sep 30, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub